Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07696052

Phosphatidylserine, Taurine, and Caffeine for Cognitive Fatigue in Professional Football Players

This randomized, double-blind, placebo-controlled, parallel-group trial will evaluate the effects of 14 days of taurine-caffeine supplementation with or without phosphatidylserine on neurocognitive fatigue resistance, visual search efficiency, and football-specific tactical decision-making in professional male football players. Sixty-two male outfield football players from two professional clubs will be randomized to placebo, taurine plus caffeine, or taurine plus caffeine plus phosphatidylserine. Laboratory and field-based outcomes will be assessed at baseline and after the supplementation period.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–37 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Professional Football Training Center, Lodz, Poland

Loading trial locations.

About this study

This study is designed to determine whether adding phosphatidylserine to a taurine-caffeine supplementation strategy supports attentional control, efficient visual search, and accurate tactical decision-making under acute neurocognitive load in professional male football players.

Participants will complete familiarization, baseline laboratory testing, baseline field testing, 14 days of supplementation, post-intervention laboratory testing, and post-intervention field testing. The laboratory protocol will include a high-load Stroop/Flanker task followed by a football-specific video decision-making task with screen-based eye-tracking. The video task will include offensive and transitional football situations requiring players to select the most appropriate tactical option under time pressure. Some clips will require inhibition of an immediately attractive but suboptimal forward action.

The primary outcome will be the change in tactical inhibitory decision accuracy under neurocognitive load from baseline to post-intervention. Secondary outcomes will include overall decision accuracy, decision time, impulsive tactical errors, mental fatigue, Stroop/Flanker reaction-time variability, time to first fixation on the optimal option, dwell time on the optimal option, situational awareness accuracy, and field-based reactive passing decision performance. Field-based transfer will be assessed using a Reactive Passing Decision Test, the Loughborough Soccer Passing Test, and standardized small-sided games.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male professional outfield football players aged 18 to 37 years.
  • First-team players or selected U19 players aged 18 years or older who are regularly integrated into first-team training.
  • Regular participation in club training.
  • At least 5 years of systematic football training experience.
  • Free from injury or illness limiting full participation in training and testing.
  • Normal or corrected-to-normal vision.
  • Ability to complete the laboratory and field-based testing procedures.
  • Written informed consent provided before participation.

Exclusion criteria

  • Goalkeepers.
  • Current injury or illness limiting full participation in testing.
  • Neurological disease.
  • Recent concussion or head trauma.
  • Uncorrected visual impairment.
  • Use of phosphatidylserine, nootropic agents, or strong stimulants during the previous 4 weeks.
  • Non-standard caffeine intake on testing days.
  • Failure to comply with pre-test standardization procedures.
  • Failed eye-tracker calibration.
  • Loss of more than 30% of gaze data during the football-specific decision-making task.
  • Withdrawal of consent.

Treatment and study plan

Placebo

Dietary Supplement

Inert placebo matched with the active supplements for appearance, number of units, and packaging. The placebo will be administered for 14 days.

Taurine Plus Caffeine

Dietary Supplement

Taurine 1500 mg/day plus caffeine 200 mg/day administered for 14 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.

Taurine, Caffeine, and Phosphatidylserine

Dietary Supplement

Taurine 1500 mg/day plus caffeine 200 mg/day plus phosphatidylserine 600 mg/day administered for 14 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.

Primary outcomes

  1. Change in Tactical Inhibitory Decision Accuracy Under Neurocognitive Load

    Time frame: Baseline and 14 days of supplementation

    Tactical inhibitory decision accuracy will be assessed using football-specific video clips requiring inhibition of an immediately attractive but suboptimal tactical action. Responses will be scored as 1 point for an optimal decision, 0.5 points for an acceptable decision, and 0 points for an incorrect decision. The outcome will be calculated as the mean score across inhibitory tactical clips. The score ranges from 0 to 1, with higher values indicating better tactical inhibitory decision accuracy.

Secondary outcomes

  1. Change in Overall Football-Specific Decision Accuracy

    Time frame: Baseline and 14 days of supplementation

    Overall football-specific decision accuracy will be assessed using video-based offensive and transitional football situations. Players will select the most appropriate tactical option under time pressure. The outcome will be expressed as the percentage of correct or expert-rated optimal decisions, with higher values indicating better decision-making accuracy.

  2. Change in Football-Specific Decision Time

    Time frame: Baseline and 14 days of supplementation

    Decision time will be assessed during the football-specific video decision-making task. It will be measured as the time taken to select a tactical response after the critical decision point. The outcome will be expressed in milliseconds, with lower values indicating faster decision-making.

  3. Change in Impulsive Tactical Errors

    Time frame: Baseline and 14 days of supplementation

    Impulsive tactical errors will be assessed during football-specific video clips. These errors will include selections of immediately attractive but suboptimal tactical options, such as inappropriate forward actions, low-quality shots, or forced progressive decisions when a safer or more appropriate option is available.

  4. Change in Stroop/Flanker Reaction-Time Variability

    Time frame: Baseline and 14 days of supplementation

    Reaction-time variability will be assessed during the high-load Stroop/Flanker task used to induce neurocognitive load. The task will assess attentional control, response inhibition, conflict monitoring, and reaction-time stability. The outcome will be expressed in milliseconds.

  5. Change in Post-Task Mental Fatigue

    Time frame: Baseline and 14 days of supplementation

    Mental fatigue will be assessed immediately after the neurocognitive load task using a visual analogue scale. The scale will range from 0 to 10, with higher scores indicating greater perceived mental fatigue.

  6. Change in Time to First Fixation on the Optimal Tactical Option

    Time frame: Baseline and 14 days of supplementation

    Time to first fixation on the optimal tactical option will be assessed using screen-based eye-tracking during the football-specific video decision-making task. The outcome will be expressed in milliseconds and will reflect how quickly the player visually orients toward the expert-defined optimal option.

  7. Change in Dwell Time on the Optimal Tactical Option

    Time frame: Baseline and 14 days of supplementation

    Dwell time on the optimal tactical option will be assessed using screen-based eye-tracking during the football-specific video decision-making task. The outcome will be expressed as the percentage of total viewing time spent fixating on the expert-defined optimal tactical option.

  8. Change in Situational Awareness Accuracy

    Time frame: Baseline and 14 days of supplementation

    Situational awareness accuracy will be assessed using probes presented after selected football-specific video clips. These probes will evaluate whether players correctly identified key tactical information, including available space, pressure location, number of defenders, teammate positioning, and defensive-line configuration.

  9. Change in Reactive Passing Decision Test Accuracy

    Time frame: Baseline and 14 days of supplementation

    Reactive Passing Decision Test accuracy will be assessed during a field-based football-specific task. Players will dribble into a decision zone and respond to a late visual or situational cue by selecting and executing the optimal passing option. The outcome will be expressed as the percentage of accurate decisions.

Study contacts

Contact information is provided by the study sponsor or research team.

Krzysztof Maciej Mizera, PhD

CONTACT

[email protected]

+48508356718

Sponsors and collaborators

Lead sponsor

Vizja University in Warsaw

Other

Registry information

Official study title

Neurocognitive Fatigue Resistance, Visual Search Efficiency, and Tactical Decision-Making After Phosphatidylserine-Containing Taurine-Caffeine Supplementation in Professional Male Football Players

Acronym: TCPS-Foot

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 10, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.